Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Feinstein

Showing results (1-10 of 219) with videos related to

Pageof 22
Sort By:
Trustee : the Journal for Hospital Governing Boards|November 6, 1984
The public's perception of hospital trusteesA L Feinstein
ASN Neuro|September 9, 2024
EditorialDouglas L Feinstein
Nature Neuroscience|March 6, 2023
Elena Galea (1962-2023)Douglas L Feinstein
Diabetes Technology & Therapeutics|May 3, 2003
Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological diseaseDouglas L Feinstein
Trustee : the Journal for Hospital Governing Boards|November 1, 1993
Community needs help keep technology in perspective. Interview by Karen GardnerA L Feinstein
Journal of Neurochemistry|April 2, 1998
Suppression of astroglial nitric oxide synthase expression by norepinephrine results from decreased NOS-2 promoter activityD L Feinstein
Journal of Neurochemistry|July 29, 1998
Potentiation of astroglial nitric oxide synthase type-2 expression by lithium chlorideD L Feinstein
Current Opinion in Hematology|October 18, 2001
Reducing transplant toxicityL Feinstein, R Storb
Current Opinion in Oncology|February 27, 2001
Nonmyeloablative hematopoietic cell transplantationL Feinstein, R Storb
Physician Executive|November 3, 1996
Will your academic department survive managed care?L Feinstein, J Temmerman
Pageof 22

Showing results (1-10 of 219) with videos related to

Sort By:
Pageof 22
Trustee : the Journal for Hospital Governing Boards|November 6, 1984
The public's perception of hospital trusteesA L Feinstein
ASN Neuro|September 9, 2024
EditorialDouglas L Feinstein
Nature Neuroscience|March 6, 2023
Elena Galea (1962-2023)Douglas L Feinstein
Diabetes Technology & Therapeutics|May 3, 2003
Therapeutic potential of peroxisome proliferator-activated receptor agonists for neurological diseaseDouglas L Feinstein
Trustee : the Journal for Hospital Governing Boards|November 1, 1993
Community needs help keep technology in perspective. Interview by Karen GardnerA L Feinstein
Journal of Neurochemistry|April 2, 1998
Suppression of astroglial nitric oxide synthase expression by norepinephrine results from decreased NOS-2 promoter activityD L Feinstein
Journal of Neurochemistry|July 29, 1998
Potentiation of astroglial nitric oxide synthase type-2 expression by lithium chlorideD L Feinstein
Current Opinion in Hematology|October 18, 2001
Reducing transplant toxicityL Feinstein, R Storb
Current Opinion in Oncology|February 27, 2001
Nonmyeloablative hematopoietic cell transplantationL Feinstein, R Storb
Physician Executive|November 3, 1996
Will your academic department survive managed care?L Feinstein, J Temmerman
Pageof 22